Canaloplasty Device
DeviceCanaloplasty
NCT Number: NCT05696561
Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma
Interested in participating?
Request Info22 year and older
All sexes
Interventional
Not applicable
Centro de la Vision, Santiago, Chile
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Canaloplasty
Time frame: Month12
Reduction in unmedicated IOP
Time frame: Month12
Percentage Change in unmedicated IOP
Time frame: Month12
Change in number of IOP lowering medications
Contact information is provided by the study sponsor or research team.
Elysia Ison, OD,FAAO
CONTACT
Swetha Mandava, MS
CONTACT
New World Medical, Inc.
Industry
A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07354516
Eye Diseases, Glaucoma
Largo, Florida, United States
View Trial DetailsNCT03931317
Eye Diseases, Glaucoma
La Jolla, California, United States
View Trial DetailsNCT05271734
Eye Diseases, Glaucoma
Tbilisi, Georgia
View Trial DetailsNCT07713056
Eye Diseases, Glaucoma
Wuhan, Hubei, China
View Trial Details